Latest Articles

The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.

C-Path, a nonprofit organization created to improve drug development, has been working to facilitate the adoption of MPS as drug development tools in regulatory science. In this interview, we learn how.

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the prevention of HIV, but also for other rapidly mutating viruses such as influenza and SARS-CoV-2.

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global markets and the innovative technologies shaping the future of pharmaceutical development.

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, monoclonal antibody therapies and gene therapies.

This article explores some of the challenges in developing cell lines for therapeutics, such as cell line stability, and how they are being addressed.

As the field of oligonucleotide therapeutics continues to evolve, the integration of robust analytical tools will be essential in advancing personalized medicine and improving patient outcomes across a wide range of diseases.

According to an annual report by My Green Lab, the biotech and pharmaceutical sectors still have some supply chain hurdles to overcome to hit their sustainability targets.

This article explores the difficulties faced in attempting to treat HIV, an innovative prevention strategy and the possibility of a cure.

RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will explore whether RNA therapeutics can realize their full potential.